[A new treatment for reduced tear production].
D000814:Aniline Compounds / Q000627:therapeutic use*; D001593:Benzyl Compounds / Q000008:administration & dosage / Q000627:therapeutic use; D002908:Chronic Disease; D003231:Conjunctivitis / Q000188:drug therapy*; D003514:Cyclohexylamines / Q000008:administration & dosage / Q000627:therapeutic use; D003594:Cytoplasmic Granules; D004847:Epithelial Cells; D005260:Female; D006056:Golgi Apparatus; D006801:Humans; D007765:Lacrimal Apparatus / Q000187:drug effects / Q000473:pathology; D008854:Microscopy, Electron; D008875:Middle Aged; D009883:Ophthalmic Solutions; D012859:Sjogren's Syndrome / Q000188:drug therapy* / Q000473:pathology; D013666:Tears / Q000378:metabolism*
D000814:Aniline Compounds; D001593:Benzyl Compounds; D003514:Cyclohexylamines; D009883:Ophthalmic Solutions
Uber eine neue Behandlungsmöglichkeit der herabgesetzten Tränenproduktion.